Treatment of Kaposi's sarcoma with actinomycin‐D and cyclophosphamide: Results of a randomtzed cltnical trial

Charles L. Vogel, Christina J. Templeton, Alexander C. Templeton, John F. Taylor, Sebastian K. Kyalwazi

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

A randomized trial of cytotoxic drugs in the treatment of florid and infiltrative types of Kaposi's sarcoma is reported. One of 10 patients treated with cyclophosphamide and nine of 12 patients treated with actinomycin D had tumour regression, demonstrating the superiority of the latter form of therapy. Patients with florid lesions responded more rapidly and completely than those with infiltrative lesions. Histologically, those tumours with the monocellular pattern accompanied by marked fibrosis or those with anaplastic variants proved to be refractory to therapy.

Original languageEnglish (US)
Pages (from-to)136-143
Number of pages8
JournalInternational Journal of Cancer
Volume8
Issue number1
DOIs
StatePublished - Jul 15 1971
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Treatment of Kaposi's sarcoma with actinomycin‐D and cyclophosphamide: Results of a randomtzed cltnical trial'. Together they form a unique fingerprint.

Cite this